Literature DB >> 24825906

EphrinB1 interacts with CNK1 and promotes cell migration through c-Jun N-terminal kinase (JNK) activation.

Hee Jun Cho1, Yoo-Seok Hwang1, Kathleen Mood1, Yon Ju Ji1, Junghwa Lim1, Deborah K Morrison1, Ira O Daar2.   

Abstract

The Eph receptors and their membrane-bound ligands, ephrins, play important roles in various biological processes such as cell adhesion and movement. The transmembrane ephrinBs transduce reverse signaling in a tyrosine phosphorylation-dependent or -independent, as well as PDZ-dependent manner. Here, we show that ephrinB1 interacts with Connector Enhancer of KSR1 (CNK1) in an EphB receptor-independent manner. In cultured cells, cotransfection of ephrinB1 with CNK1 increases JNK phosphorylation. EphrinB1/CNK1-mediated JNK activation is reduced by overexpression of dominant-negative RhoA. Overexpression of CNK1 alone is sufficient for activation of RhoA; however, both ephrinB1 and CNK1 are required for JNK phosphorylation. Co-immunoprecipitation data showed that ephrinB1 and CNK1 act as scaffold proteins that connect RhoA and JNK signaling components, such as p115RhoGEF and MKK4. Furthermore, adhesion to fibronectin or active Src overexpression increases ephrinB1/CNK1 binding, whereas blocking Src activity by a pharmacological inhibitor decreases not only ephrinB1/CNK1 binding, but also JNK activation. EphrinB1 overexpression increases cell motility, however, CNK1 depletion by siRNA abrogates ephrinB1-mediated cell migration and JNK activation. Moreover, Rho kinase inhibitor or JNK inhibitor treatment suppresses ephrinB1-mediated cell migration. Taken together, our findings suggest that CNK1 is required for ephrinB1-induced JNK activation and cell migration.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CNK1; Cell Migration; Eph; Ephrin; Ras Homolog Gene Family, Member A (RhoA); Scaffold Protein; Signal Transduction; c-Jun N-terminal Kinase (JNK)

Mesh:

Substances:

Year:  2014        PMID: 24825906      PMCID: PMC4140269          DOI: 10.1074/jbc.M114.558809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho.

Authors:  Aron B Jaffe; Alan Hall; Anja Schmidt
Journal:  Curr Biol       Date:  2005-03-08       Impact factor: 10.834

2.  Phosphorylation of ephrin-B1 via the interaction with claudin following cell-cell contact formation.

Authors:  Masamitsu Tanaka; Reiko Kamata; Ryuichi Sakai
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

3.  CNK1 is a scaffold protein that regulates Src-mediated Raf-1 activation.

Authors:  Algirdas Ziogas; Karin Moelling; Gerald Radziwill
Journal:  J Biol Chem       Date:  2005-04-21       Impact factor: 5.157

4.  EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1.

Authors:  Fumitoshi Irie; Misako Okuno; Elena B Pasquale; Yu Yamaguchi
Journal:  Nat Cell Biol       Date:  2005-04-10       Impact factor: 28.824

5.  Ephrin signalling controls brain size by regulating apoptosis of neural progenitors.

Authors:  Vanessa Depaepe; Nathalie Suarez-Gonzalez; Audrey Dufour; Lara Passante; Jessica A Gorski; Kevin R Jones; Catherine Ledent; Pierre Vanderhaeghen
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

Review 6.  Eph receptor signalling casts a wide net on cell behaviour.

Authors:  Elena B Pasquale
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

7.  The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Galpha12.

Authors:  M Nagao; Y Kaziro; H Itoh
Journal:  Oncogene       Date:  1999-08-05       Impact factor: 9.867

8.  Integrinalpha5-dependent fibronectin accumulation for maintenance of somite boundaries in zebrafish embryos.

Authors:  Sumito Koshida; Yasuyuki Kishimoto; Hideko Ustumi; Toshihiro Shimizu; Makoto Furutani-Seiki; Hisato Kondoh; Shinji Takada
Journal:  Dev Cell       Date:  2005-04       Impact factor: 12.270

9.  EphB receptor activity suppresses colorectal cancer progression.

Authors:  Eduard Batlle; Julinor Bacani; Harry Begthel; Suzanne Jonkheer; Suzanne Jonkeer; Alexander Gregorieff; Maaike van de Born; Núria Malats; Elena Sancho; Elles Boon; Tony Pawson; Steven Gallinger; Steven Pals; Hans Clevers
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

10.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

Authors:  R H Adams; G A Wilkinson; C Weiss; F Diella; N W Gale; U Deutsch; W Risau; R Klein
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

View more
  11 in total

1.  The C. elegans NR4A nuclear receptor gene nhr-6 promotes cell cycle progression in the spermatheca lineage.

Authors:  Brandon Praslicka; Chris R Gissendanner
Journal:  Dev Dyn       Date:  2015-01-24       Impact factor: 3.780

Review 2.  Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis.

Authors:  Brian Wu; Jason S Rockel; David Lagares; Mohit Kapoor
Journal:  Curr Rheumatol Rep       Date:  2019-04-12       Impact factor: 4.592

3.  Nephrin-Binding Ephrin-B1 at the Slit Diaphragm Controls Podocyte Function through the JNK Pathway.

Authors:  Yoshiyasu Fukusumi; Ying Zhang; Ryohei Yamagishi; Kanako Oda; Toru Watanabe; Katsuyuki Matsui; Hiroshi Kawachi
Journal:  J Am Soc Nephrol       Date:  2018-03-30       Impact factor: 10.121

4.  Δ9-Tetrahydrocannabinol (Δ9-THC) Promotes Neuroimmune-Modulatory MicroRNA Profile in Striatum of Simian Immunodeficiency Virus (SIV)-Infected Macaques.

Authors:  Liz Simon; Keijing Song; Curtis Vande Stouwe; Andrew Hollenbach; Angela Amedee; Mahesh Mohan; Peter Winsauer; Patricia Molina
Journal:  J Neuroimmune Pharmacol       Date:  2015-11-25       Impact factor: 4.147

Review 5.  EphB/ephrinB signaling in cell adhesion and migration.

Authors:  Inji Park; Hyun-Shik Lee
Journal:  Mol Cells       Date:  2014-12-04       Impact factor: 5.034

6.  Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer.

Authors:  Humair S Quadri; Taylor J Aiken; Michael Allgaeuer; Radim Moravec; Sean Altekruse; S Perwez Hussain; Markku M Miettinen; Stephen M Hewitt; Udo Rudloff
Journal:  BMC Cancer       Date:  2017-07-21       Impact factor: 4.430

Review 7.  Paradoxes of the EphB1 receptor in malignant brain tumors.

Authors:  Wenqiang Wei; Hongju Wang; Shaoping Ji
Journal:  Cancer Cell Int       Date:  2017-02-08       Impact factor: 5.722

8.  TBC1d24-ephrinB2 interaction regulates contact inhibition of locomotion in neural crest cell migration.

Authors:  Jaeho Yoon; Yoo-Seok Hwang; Moonsup Lee; Jian Sun; Hee Jun Cho; Laura Knapik; Ira O Daar
Journal:  Nat Commun       Date:  2018-08-28       Impact factor: 14.919

9.  The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells.

Authors:  Yan Zhou; Yuanliang Zhang; Hanbing Zou; Ning Cai; Xiaojing Chen; Longmei Xu; Xianming Kong; Peifeng Liu
Journal:  Sci Rep       Date:  2015-02-27       Impact factor: 4.379

10.  EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1.

Authors:  H J Cho; Y-S Hwang; J Yoon; M Lee; H G Lee; I O Daar
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.